A medical-based blockchain that utilizes AI & telomere for age reversal
defytime OÜ (headquarter: Estonia, President & CEO Johnathan Greenword), a company missioned to maximize the beneficiaries and social values of the health span effect is proud to present the launching of the third crowd-sale of Telomere Coin (TXY) from July 6th to July 15th.
The Telomere Coin will be available at 1TXY/ $7 USD, and will also accept BTC, ETH, XRP. The ICO started its presale of Telomere Coin on May 2nd, 2018 and will end at July 15th, 2018 with the third crowd-sale.
Details of Telomere Coin
Why do people become unhealthy?
Human Health = Telomere Length
– Solution –
Discovered by molecular biologist Dr. Bill Andrews, telomere and telomerase are the key to unlocking mankind’s dream of eternal youth and longevity.
– Future –
Comprehensive Economic System for the Cutting Edge Telomere Treatment
Important Notes About Purchase
– Purchasers should follow the ICO regulations of their country of residence.
– The residents of the United States of America and the residents of the People’s Republic of China cannot participate in this ICO.
– Even those who cannot purchase ICO can buy our products and use our services in the future with their own Telomere coins.
– Telomere coin is an ERC20 token. Any ERC20 compatible wallet such as MetaMask, MyEtherWallet, and Mist will work. If funds are transferred from a Coinbase or exchange base wallet, users will not be able to retrieve their tokens.
About Chief Scientific Officer –Dr. Bill Andrews
Bill Andrews, Ph.D., is founder and CEO, is a scientist, athlete and executive who is known for pushing the envelope and for challenging convention. Featured in numerous publications, TV shows and documentaries on the topic of life extension, Bill Andrews is one of the principal discoverers of both the RNA and protein components of human telomerase, and was awarded 2nd place as National Inventor of the Year in 1997. On top of his in-depth experience, Bill is also the inventor of 50+ U.S. Patents issued on telomerase and author of numerous scientific research studies published in peer reviewed scientific journals.
About defytime OÜ
Headquarters: Harju maakond, Tallinn, Kesklinna linnaosa, Narva mnt 5, 10117
President and CEO: Jonathan Greenwood
Establishment: April 23,2018
Description of business:
1.Research on diseases caused by telomere shortening and the development of solutions.
2.Research, planning and development for the purpose of industrializing biotechnology.
3.Consulting services related to each of the aforementioned items.
4.All activities accompanying each of the aforementioned items.
For more information, please contact: